PNPLA3 and cardiovascular disorder: The genetic variants in PNPLA3 and TM6SF2 are only responsible for ~50% of NAFLD patients [120], and majority of PNPLA3-associated NAFLD patients are not obese and have no insulin resistance and its related diabetes and cardiovascular diseases [140].